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Abstract
Background Patient experience is acknowledged as a principal aspect of quality healthcare delivery, and it has implications 
with regard to outcomes.
Objectives Our objective was to evaluate the healthcare experience of patients with chronic diseases to identify patient-
perceived healthcare gaps and to assess the influence of demographic and healthcare-related variables on patient experiences.
Methods A cross-sectional survey was delivered to adult patients with chronic diseases: diabetes mellitus (DM), human 
immunodeficiency virus (HIV) infection, inflammatory bowel disease (IBD) or rheumatic diseases. Patient experiences were 
assessed with the Instrument for Evaluation of the Experience of Chronic Patients (IEXPAC) questionnaire, with possible 
scores ranging from 0 (worst) to 10 (best experience).
Results Of the 2474 patients handed the survey, 1618 returned it (response rate 65.4%). Patients identified gaps in healthcare 
related mainly to access to reliable information and services, interaction with other patients and continuity of healthcare 
after hospital discharge. The mean ± standard deviation (SD) IEXPAC score was 6.0 ± 1.9 and was higher for patients with 
HIV (6.6 ± 1.7) than for those with rheumatic disease (5.5 ± 2.0), IBD (5.9 ± 2.0) or DM (5.9 ± 1.9) (p < 0.001). In multivari-
ate models, better overall IEXPAC experience was associated with follow-up by the same physician, follow-up by a nurse, 
receiving healthcare support from others and treatment with subcutaneous or intravenous drugs. The multivariate model that 
confirmed patients with HIV or DM had better experience than did those with rheumatic diseases.
Conclusions Through IEXPAC, patients identified aspects for healthcare quality improvements and circumstances associated 
with better experience, which may permit greater redirection of healthcare toward patient-centered goals while facilitating 
improvements in social care and long-term healthcare quality.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s4027 1-018-0345-1) contains 
supplementary material, which is available to authorized users.
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Key Points for Decision Makers 
Broad use of the Instrument for Evaluation of the Expe-
rience of Chronic Patients (IEXPAC) scale or similar 
instruments in routine practice with patients with chronic 
conditions will likely identify and reinforce areas to be 
pursued to attain continued improvements in healthcare 
quality.
Patients with chronic diseases should be particularly pro-
active in steering integrated social care and healthcare 
toward patient-centered goals.
Further research is now warranted to identify and imple-
ment actions to address gaps and clearly define whether 
IEXPAC score improvements are linked directly with 
improvements in clinical effectiveness and health-related 
quality of life in patients with chronic conditions.
1 Introduction
Besides clinical effectiveness and safety, patient experience 
is widely acknowledged as a principal measure of quality 
healthcare delivery to patients with chronic diseases [1]. 
The provision of well-planned, proactive and integrated 
patient-centered care has been associated with enhanced 
patient experience and clinical outcomes in patients with 
chronic diseases [2–5]. Indeed, patient experience (e.g., as 
an inpatient) may involve factors such as attention to analge-
sia, assistance with feeding, type of environment (e.g., low 
noise, cleanliness) and dedication of healthcare profession-
als; all these factors may provide a holistic perspective of 
overall healthcare quality. Such a perspective may ultimately 
provide more meaningful information than specific measures 
of clinical effectiveness and patient safety [1, 6].
Quality-of-care improvements over time lead to a more 
positive experience for patients with chronic conditions [7], 
and careful measurement of patient experience can provide 
significant data to facilitate further enhancements in quality 
of care, clinical effectiveness and patient safety [1, 2].
Traditional instruments used for assessing patient experi-
ence of chronic care delivery include the Patient Assessment 
of Chronic Illness Care (PACIC) scale [8] and the Patient 
Perceptions of Integrated Care (PPIC) survey [9, 10]. The 
PACIC scale has been widely used worldwide in various 
chronic illnesses and has been defined as the most relevant 
scale for assessing patient perspectives of integrated long-
term quality of care [2, 11]. The PPIC survey evaluates 
integrated quality of care using a six-dimension model. 
However, neither PACIC nor PPIC includes aspects relat-
ing to developments in information and communications 
technology in chronic healthcare, and neither directly evalu-
ates interactions between social care and healthcare provid-
ers [2].
The Instrument for Evaluation of the Experience of 
Chronic Patients (IEXPAC; available online at http://www.
iexpa c.org) was developed recently and has several key 
advantages over existing instruments for assessing patient 
experience of chronic care delivery. It focuses on interac-
tion between patients and healthcare teams rather than spe-
cific healthcare professionals. It also incorporates a broader 
notion of integrated care, including social care and patient 
self-management. Finally, the IEXPAC includes new ways 
of assessing patient–healthcare interactions using new tech-
nologies and patient–patient interactions. Therefore, this 
instrument can assist in determining the quality of care pro-
vided according to the Triple Aim framework (i.e., improv-
ing the individual experience of care, improving the health 
of populations and reducing the per capita costs of care for 
populations [12]), facilitating reorientation of health system 
resources from healthcare professionals toward integrated 
patient-centered care [2].
To gain greater understanding of the potential variables 
influencing patient experience when measured with the IEX-
PAC, and potential associations with other important aspects 
of patient care, we designed a survey that was addressed to 
patients with one of four different chronic conditions: rheu-
matic diseases, inflammatory bowel disease (IBD), human 
immunodeficiency virus (HIV) infection and diabetes mel-
litus (DM). The current work displays outcomes of the main 
study objective, namely to assess the healthcare experience 
of patients with chronic diseases using the IEXPAC, to iden-
tify patient-perceived gaps in healthcare and to assess the 
influence of demographic and healthcare-related variables 
on patient experience.
2  Methods
2.1  Study Design
This was a cross-sectional survey of patients with chronic 
conditions aged > 18 years who required healthcare on at 
least two different levels (e.g., primary care and outpa-
tient specialty clinic). Four different patient profiles were 
selected: patients with rheumatic disease (rheumatoid arthri-
tis or spondyloarthritis) recruited from outpatient hospital 
clinics, patients with IBD recruited from outpatient hospi-
tal clinics, patients with HIV infection recruited from HIV 
units or internal medicine clinics and patients with DM who 
also had a diagnosis of cardiovascular or chronic renal dis-
ease, selected from primary care clinics. The survey was 
handed to patients by their physician or nurse. Patients were 
instructed to read the survey and complete it voluntarily and 
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anonymously from home, and then return it by pre-paid mail 
(see the Electronic Supplementary Material (ESM) 1).
Investigators from the specialties involved in the care of 
these patients were selected from a wide sample of outpa-
tient hospitals and primary care clinics across the different 
regions of Spain to be representative of the Spanish health-
care system (ESM 2). To minimize selection bias, each 
physician or nurse (25 from rheumatology teams, 23 from 
gastroenterology teams and 25 from HIV clinics) handed 
the survey to the first 25 consecutive patients attending the 
clinic routinely, regardless of age, sex, disease severity or 
any other criterion. In addition, 48 primary care physicians 
each handed the survey to 13 consecutive patients with DM. 
Surveys were distributed and collected between May and 
September 2017.
Taking the IEXPAC 2015 (version 11 + 1) scale as the 
starting point, a survey was developed for this study with 
the participation of four physicians expert in the treatment 
of the abovementioned conditions. The survey was reviewed 
by members of three patients’ associations [the Spanish 
Association of Patients with Arthritis (CONARTRITIS), 
the Spanish Association of Patients with Crohn’s Disease 
and Ulcerative Colitis (ACCU) and the Spanish Federa-
tion of Patients with Diabetes (FEDE)] and by members of 
the Spanish AIDS Multidisciplinary Society (SEISIDA), a 
Spanish Society composed of patients with HIV and differ-
ent healthcare professionals. Patients reviewed the content 
and relevance of the questions, and the language used, and 
suggested modifications or additional questions. Except for 
validated questionnaires including IEXPAC, which were not 
modified, suggestions from patients were included in the 
final version of the survey.
The study was reviewed and approved by the Clinical 
Investigation Ethics Committee of the Gregorio Marañón 
Hospital of Madrid, Spain. The study documentation 
included printed instructions and information for patients 
about the anonymous nature of the survey and aggregated 
data processing, which ensured that patient identification 
was not possible. As agreed by the Clinical Investigation 
Ethics Committee, the voluntary return of completed ques-
tionnaires was taken as implied consent to participate in the 
study. No clinical data were collected in this study.
2.2  Survey Instrument
The survey included multiple-choice questions that provided 
information about patient demographics, healthcare-related 
characteristics, disability (Barthel index) [13], follow-up by 
different specialists or nurses and treatment characteristics 
(ESM 3). As part of the survey, we included the whole IEX-
PAC questionnaire verbatim to assess patients’ experience 
with healthcare. The first version (version 11 + 1), which 
was used in this study, was developed in 2015 through a 
comprehensive process of literature review, expert panel 
work (including healthcare professional and social organi-
zations, experts in quality of healthcare and patients with 
chronic conditions) and pilot and field work with 356 
patients with chronic conditions to assess questionnaire 
content and face validity and reliability [2].
The IEXPAC scale was designed to be self-adminis-
tered by patients. It has 11 items, plus an additional item 
for patients recently hospitalized. The items refer to the 
previous 6 months, except the question about hospitaliza-
tion, which refers to the previous 3 years. For each item, 
patients responded on a 5-point Likert scale, and responses 
are transformed into scores: always (score 10), mostly (7.5), 
sometimes (5), seldom (2.5) or never (0). The scale yields 
an overall score (sum of individual scores for the 11 items 
divided by 11) between 0 (worst experience) and 10 (best 
experience) and allows identification of items in which 
improvement is needed.
Three factors are derived from the first 11 items of IEX-
PAC. Factor 1 is named “productive interactions” and refers 
to the characteristics and content of interactions between 
patients and professionals designed to improve outcomes. 
The productive interactions score is the average of the scores 
for items 1, 2, 5 and 9. Factor 2, the “new relational model,” 
refers to new forms of patient interaction with the health-
care system, through the internet or with peers. The score 
for factor 2 is the average of scores for items 3, 7 and 11. 
Finally, factor 3, named “patient self-management,” refers to 
the ability of individuals to cope with their diseases, manage 
their own care and improve their well-being, based on inter-
ventions mediated by healthcare professionals. The patient 
self-management score is the average of scores for items 4, 
6, 8 and 10. The 12th item refers to continuity after hospital-
ization and is described separately. The IEXPAC question-
naire showed acceptable internal consistency (Cronbach’s 
α 0.76) and independence among the different factors [2].
2.3  Statistical Analysis
The survey was exploratory, and no formal hypothesis or 
pre-specified sample size was calculated. Conservatively, 
estimates based on a qualitative variable with 50% as the 
expected prevalence, a confidence interval of 95% and 
precision of 6% would give a sample size of 267 patients. 
Assuming that 15% of questionnaires would be incorrectly 
completed by patients, the total sample size for recruitment 
would be 314 patients. However, the expected response rate 
also had to be added to permit calculation of the final num-
ber of surveys required. Assuming a response rate of 50%, as 
seen in other surveys handed to patients [14, 15], our survey 
would have to be handed to approximately 628 patients. As 
we included four different patient profiles, we planned to 
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hand the survey to approximately 2500 patients (625 patients 
with each background disease).
Descriptive information is displayed as mean ± standard 
deviation (SD) for quantitative variables, and as frequencies 
or percent for qualitative variables. For results of the IEX-
PAC questionnaire, we calculated the mean ± SD score for 
each item, the overall mean ± SD score and the mean ± SD 
scores for the three abovementioned factors. For this calcula-
tion, patients without a response to one IEXPAC item were 
imputed using the mean value of all respondents for that 
item. Patients lacking a response to more than one item were 
excluded from this analysis. The distribution of responses 
to individual items is also displayed, as is the sum of the 
percent of “always” plus “mostly” responses to each item.
We used Chi-squared or Fisher’s exact tests to compare 
proportions and the Student’s t test or analysis of variance 
(ANOVA) to compare continuous variables. Multiple linear 
regression models were used to assess the different demo-
graphic and healthcare-related variables influencing IEX-
PAC overall score, and the scores for each factor. Variables 
that were a priori considered to have the potential to influ-
ence patient experience were included in the model. Beta 
coefficients ± SD with p values are shown. Given the overall 
descriptive nature of the results, no multiplicity adjustments 
were made. There was no imputation for missing data.
3  Results
3.1  Survey Population
The survey was handed to 2474 patients and was returned 
by 1618 patients (response rate 65.4%). The final sample 
comprised 359 patients with rheumatic disease (22.2%), 
341 with IBD (21.1%), 467 with HIV infection (28.9%) and 
451 with DM (27.9%). Mean age was 56.2 ± 14.7 years, and 
59.1% of patients were male. The principal characteristics 
of the survey population are shown in Table 1. Only 6.1% of 
patients were affiliated with a patients’ association. A total 
61.3% of patients searched for healthcare information from 
sources other than healthcare providers (i.e., the internet or 
media).
In terms of healthcare-related characteristics, patients 
had visited a mean of four specialists (including primary 
care physician) in the past year, and 19.3% of patients 
declared that they sometimes or frequently saw a different 
treating physician; this value was substantially higher in 
patients with DM (33.2%). Regular follow-up by a nurse was 
reported by 58.0% of patients overall, with a higher value 
reported by patients with DM (82.7%). Overall, patients 
were being treated with a mean of 4.7 different medications 
daily, and 31.1% of patients were receiving subcutaneous or 
intravenous medications. During the past 3 years, 48.2% of 
patients had been hospitalized, for any reason, at least once.
3.2  IEXPAC Responses and Experience Scores
Figure 1 shows the distribution of responses to the 12 IEX-
PAC items, and mean ± SD scores, and Table 2 shows the 
percent of patients who responded “always” or “mostly” 
according to background disease. Generally, the proportion 
of patients who responded “always” or “mostly” was high 
(> 70%) for items related to factors 1 and 3 (i.e., productive 
interactions and patient self-management), except for item 
10 (information about health and social resources), but was 
low for items related to factor 2 (new relational model). The 
proportion of patients who responded “always” or “mostly” 
was especially low (≤ 15%) for the items “they help me to 
get information from the internet,” “I can use the internet 
and my mobile phone to consult my medical records” and 
“they encourage me to talk to other patients.” Only 30.6% of 
those who had been hospitalized in the past 3 years received 
a regular follow-up call or visit after hospital discharge 
(item 12). For most items, the proportions of patients who 
responded “always” or “mostly” were higher in patients with 
HIV infection (Table 2).
Figure 2 shows the distribution of overall IEXPAC expe-
rience scores. About 60% of patients scored between 5 and 
8. The mean ± SD IEXPAC score was 6.0 ± 1.9. Scores were 
higher for productive interactions and patient self-manage-
ment but lower for the new relational model factor (Table 3). 
All scores were higher in patients with HIV infection and 
lower in patients with rheumatic disease (Table 3).
The scores stratified by different demographic and health-
care-related characteristics are displayed as supplementary 
tables (ESM 4–13). Table 4 shows a summary of the bivari-
ate study. Several scores (overall experience, productive 
interactions and patient self-management) were slightly 
higher in males than in females. Scores stratified according 
to age quartiles were similar, except for the new relational 
model score (factor 2), which was higher in younger age 
groups (ESM 5). Patients with fewer specialist visits in the 
past year, who were usually followed-up by the same physi-
cian or who received regular follow-up by a nurse had better 
overall experience scores. All experience scores were better 
in patients treated with fewer different medications (Table 4; 
ESM 12).
3.3  Multivariate Analysis
Table 5 shows results from the multiple linear regression 
models. After adjustment for demographic and healthcare-
related variables, patients with HIV had better experience 
scores in all cases, and the DM group had higher overall 
IEXPAC experience, productive interactions and patient 
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self-management scores than patients with rheumatic 
disease.
A better overall IEXPAC experience score (higher score) 
was associated with follow-up by the same versus a differ-
ent physician, follow-up by a nurse, receiving support from 
others for healthcare rather than self-care and treatment with 
subcutaneous or intravenous drugs. Follow-up by more spe-
cialists in the previous year was associated with a signifi-
cantly lower overall IEXPAC experience score (Table 5).
Regular follow-up by the same versus a different physi-
cian, follow-up by a nurse and treatment with subcutaneous 
or intravenous drugs were associated with better produc-
tive interactions and patient self-management scores. Con-
versely, more specialist visits in the previous year was asso-
ciated with worse scores for these two factors. Follow-up 
by a nurse, support from others for healthcare, younger age 
and higher educational level achieved were associated with 
higher new relational model scores. The goodness of fit (R2) 
test was low for the four models described (R2 for the overall 
IEXPAC score: 0.121, Table 5), suggesting that the model 
explained only a small part of the variability.
4  Discussion
This cross-sectional survey included 1618 patients with 
chronic diseases, with an approximately even distribution 
of patients between groups according to background dis-
ease: DM, HIV infection, IBD or rheumatic disease. The 
survey identified several areas to be targeted for potential 
healthcare quality enhancement in chronically ill patients. 
For instance, low rates of “always” or “mostly” responses 
were evident for items relating to assistance in getting infor-
mation from the internet, ability to use the internet and a 
mobile phone to access medical records and encouragement 
to talk to other patients. Indeed, > 60% of patients searched 
Table 1  Principal characteristics of survey respondents
Data are presented as % or mean ± standard deviation unless otherwise noted
All p < 0.05, except for the item “Follow-up for healthcare in a Spanish region different from the patient’s main residence” (p = 0.075)
DM diabetes mellitus, HIV human immunodeficiency virus, IBD inflammatory bowel disease
Characteristic All patients (n = 1618) Rheumatic 
disease 
(n = 359)
IBD (n = 341) HIV (n = 467) DM (n = 451)
Patient demographics
 Age 56.2 ± 14.7 54.6 ± 13.9 46.8 ± 12.9 51.6 ± 10.9 69.5 ± 10.1
 Sex, men 59.1 36.7 51.8 73.5 67.8
 Educational level achieved
  Primary 42.5 43.8 30.2 42.4 50.8
  Secondary, including vocational 34.5 32.5 32.1 35.9 28.8
  University or further 23.0 23.6 27.8 21.7 20,4
 Barthel index ≤ 80 8.2 13.1 2.1 8.3 9.0
 Affiliated with patients’ association 6.1 6.2 10.1 4.4 4.6
 Searched for information about healthcare from sources 
other than healthcare providers (i.e., internet, media, 
etc.)
61.3 67.7 73.4 59.5 48.9
Healthcare-related characteristics
 Follow-up for healthcare in a Spanish region different 
from the patient’s main residence
7.2 7.9 7.8 8.8 4.4
 Number of different specialists (including primary 
care) visited in the past year
4.0 ± 2.3 4.3 ± 2.6 3.8 ± 2.1 3.9 ± 2.4 4.0 ± 2.4
 Patient follow-up
  Generally by the same physician 80.7 84.9 85.2 87.4 66.8
  Sometimes different 14.9 11.2 10.6 10.5 26
  Frequently different 4.4 3.9 4.2 2.1 7.2
  Follow-up by a nurse 58.0 49.0 44.3 51.0 82.7
 No support from others (relatives or friends, caregiver) 
for healthcare (self-care)
59.1 53.2 59.2 67.9 54.8
 Number of medicines taken daily 4.7 ± 3.2 4.4 ± 2.6 3.5 ± 2.4 4.0 ± 3.4 6.5 ± 3.2
 Treated with subcutaneous or intravenous medications 31.1 58.5 42.2 8.4 23.9
312 D. Orozco-Beltrán et al.
for healthcare information from sources other than their 
healthcare provider (i.e., the internet or media), and only 
6.1% of patients were affiliated with a patients’ association 
to facilitate patient–patient communication, which highlights 
the importance of implementing actions to guide patients 
in obtaining information from trusted sources and in estab-
lishing productive communication with other patients [16, 
17]. Overall, although scores for productive interactions and 
patient self-management factors were generally satisfactory, 
scores for the new relational model factor were very low in 
all four subgroups of background disease. There are opportu-
nities for improvement in current healthcare models, taking 
advantage of new technologies and communication chan-
nels and personalizing the approach according to patients’ 
profiles and wishes [18]. In addition, less than one-third of 
patients received a regular follow-up call or visit after hos-
pital discharge which, given the high percentage of patients 
who declared having been hospitalized, identifies a clear 
area for improvement.
Patients with rheumatic disease tended to have the lowest 
IEXPAC scores for overall patient experience and for each 
of factors 1–3, whereas patients with HIV tended to have the 
highest scores. The latter finding suggests that the extent of 
personalized quality healthcare in patients with HIV may 
be greater than that in those with other chronic conditions 
(e.g., rheumatic disease) in Spain. This may be due to several 
reasons, including the prioritization and larger investment 
given several years ago to the care of patients living with 
HIV [19–21]. Potentially, if our findings are verified in other 
studies, then the quality of healthcare for patients with HIV 
can be used as an “aspirational standard” or requisite target 
level of healthcare quality to be attained in the management 
of other chronic illnesses.
Importantly, variables associated with better IEXPAC 
scores for overall patient experience, and the productive 
interactions, new relational model and patient self-man-
agement factors, were fewer specialist visits in the previous 
year, follow-up by the same rather than a different physician 
and fewer different medicines taken. Multivariate analysis 
revealed that overall IEXPAC scores for patient experience 
were significantly better when patients were followed-up by 
the same rather than a different physician, were followed-
up by a nurse, had healthcare help from others rather than 
relying on self-care and were treated with subcutaneous or 
intravenous drugs. This reflects the importance of nursing 
in the management of chronic diseases [22–26] and of sim-
plifying patients’ care by reducing the number of special-
ists seeing the patient. The fact that patients who were seen 
regularly by the same physician described better experiences 
suggests a level of emotional engagement and trust that can 
lower when the physician changes. In addition, patients with 
IBD, HIV infection or DM all had significantly better overall 
IEXPAC patient experience scores than patients with rheu-
matic disease.
As outlined, the IEXPAC instrument used in our survey 
has some advantages over traditionally used instruments 
such as the PACIC scale [8] and PCIC survey [9, 10]. IEX-

























































12. They care about me when I come home after being in hospital
11.They encourage me to talk to other patients
10. I have been informed about health and social resources that
can help me
9. They worry about my welfare
8. They make sure that I take medication correctly
7. I can use the internet and my mobile phone to consult my
medical records
6. We set goals for a healthy life and better control my illness
5. They ask me and help me to follow my treatment plan
4. Now I can take care of myself better
3. They help me to get information from the internet
2. They are coordinated to offer good health care to me
1.They respect my lifestyle
















Fig. 1  Frequency distribution of patients’ responses to Instrument for Evaluation of the Experience of Chronic Patients (IEXPAC) items. SD 
standard deviation
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and other patients and also includes aspects of social care, 
patient self-management and technologic innovation [2]. 
Nevertheless, our study had some limitations. As this was 
an anonymous survey, we do not know the patient profiles 
of those who did not return the survey or their reasons for 
not responding. In general, these kinds of voluntary surveys 
tend to generate responses more frequently from motivated 
patients or patients who are particularly worried about their 
health. The consecutive inclusion of patients reduces selec-
tion bias but does not eliminate it: patients with more severe 
conditions, who are seen more frequently, are more likely 
to be invited to participate. However, it is this population 
who will potentially benefit more from any improvements 
implemented in the healthcare system. Also, study outcomes 
refer to specific patients’ profiles. On one hand, these are 
not representative of the overall population of patients with 
Table 2  Responses to IEXPAC items
DM diabetes mellitus, HIV human immunodeficiency virus, IBD inflammatory bowel disease, IEXPAC Instrument for Evaluation of the Experi-
ence of Chronic Patients




ease (n = 359)
IBD (n = 341) HIV (n = 467) DM (n = 451) p value
1. They respect my lifestyle. The professionals who care for me 
listen to me and ask me about my needs, habits and preferences 
to adapt my treatment and care plan (n = 1591)
81.5 76.5 75.1 89.6 81.9 < 0.001
2. They are coordinated to offer good healthcare to me. Health 
and social care services are coordinated to improve my well-
being and quality of life in my environment (family, neighbor-
hood, town) (n = 1533)
69.3 60.6 61.9 76.8 73.3 < 0.001
3. They help me to get information from the internet. The 
professionals who care for me inform me about trustful web 
pages and internet forums that I can consult to better know my 
disease, its treatment, and possible consequences on my life 
(n = 1531)
15.0 12.8 19.0 19.8 8.3 < 0.001
4. Now I can take care of myself better. I feel that my confi-
dence in my ability to take care of myself, manage my health 
problems and keep my autonomy has improved (n = 1529)
81.0 74.3 79.3 89.7 78.3 < 0.001
5. They ask me and help me to follow my treatment plan. I 
regularly review adherence to my treatment and care plan with 
the professionals who care for me (n = 1534)
79.8 73.5 77.8 87.6 78.2 < 0.001
6. We set goals for a healthy life and better control my illness. 
I’ve been able to agree with the professionals who care for me 
about specific objectives for diet, physical exercise and medica-
tion to get better control of my health problems (n = 1536)
70.1 63.4 62.6 74.7 76.1 < 0.001
7. I can use the internet and my mobile phone to consult my 
medical records. I can consult my clinical records, test results, 
programmed visits, and access other services through the inter-
net or mobile app of my health service (n = 1521)
7.2 7.3 5.5 8.6 7.1 0.529
8. They make sure that I take medication correctly. The pro-
fessionals who care for me review with me all of the medication 
I take, how I take it, and how it suits me (n = 1543)
76.0 72.4 73.7 83.5 72.9 < 0.001
9. They worry about my welfare. The professionals who care 
for me are concerned with my quality of life, and I feel they are 
committed to my well-being (n = 1547)
84.3 79.1 80.4 91.5 83.8 < 0.001
10. I have been informed about health and social resources 
that can help me. The professionals who care for me inform 
me about the health and social resources available in my neigh-
borhood or town that I can use to improve my health problems 
and take better care of myself (n = 1515)
41.3 33.8 32.3 52.6 42.3 < 0.001
11. They encourage me to talk to other patients. The profes-
sionals who care for me invite me to participate in patient 
groups to share information and experiences about how to care 
for ourselves and improve our health (n = 1513)
14.9 10.3 15.7 20.4 12.0 < 0.001
Respond to the following statement only if you have been admit-
ted to hospital in the last 3 years:
12. They care about me when I come home after being in 
hospital. After hospital discharge, they called or visited me at 
home to see how I was and what care I needed (n = 780)
30.6 25.7 28.9 33.0 32.8 0.205
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chronic conditions; on the other hand, the specific outcomes 
of each population deserve future study. Although the multi-
variate models explained only a small part of the variability, 
factors were identified that, if corrected, have the potential 
to improve healthcare quality and patient experience. To 
the best of our knowledge, this is the first study to evaluate 
factors related to better patient experience as measured by 
the IEXPAC, so future studies should be conducted to con-
firm our findings. Further, definitive data are lacking about 
whether IEXPAC score improvements are linked directly 
with improvements in clinical effectiveness and health-
related quality of life. The situation also arises that different 
scales may be needed to adequately assess healthcare qual-
ity for patients with chronic diseases in different care set-
tings, such as patients in nursing home programs or patients 
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Fig. 2  Frequency distribution of overall Instrument for Evaluation of 
the Experience of Chronic Patients (IEXPAC) experience scores
Table 3  IEXPAC experience scores: Overall scores and scores for the different factors
Data are presented as mean ± standard deviation
DM diabetes mellitus, HIV human immunodeficiency virus, IBD inflammatory bowel disease, IEXPAC Instrument for Evaluation of the Experi-




ease (n = 359)
IBD (n = 341) HIV (n = 467) DM (n = 451) p value
Overall IEXPAC experience score 6.0 ± 1.9 5.5 ± 2.0 5.9 ± 2.0 6.6 ± 1.7 5.9 ± 1.9 < 0.001
Productive interactions (factor 1) 8.0 ± 2.2 7.5 ± 2.5 7.7 ± 2.7 8.6 ± 1.8 7.9 ± 2.1 < 0.001
New relational model (factor 2) 2.0 ± 2.3 1.7 ± 2.2 2.2 ± 2.2 2.4 ± 2.5 1.7 ± 2.0 < 0.001
Patient self-management (factor 3) 7.1 ± 2.3 6.5 ± 2.5 6.7 ± 2.4 7.8 ± 2.0 7.1 ± 2.6 < 0.001
Table 4  Bivariate analysis: variables associated with better IEXPAC experience scores
See Electronic Supplementary Material 4–13 for more information
The table displays values for variables associated with better experience scores in the bivariate analysis (p < 0.05)
IEXPAC Instrument for Evaluation of the Experience of Chronic Patients, IV intravenous, SC subcutaneous












Age – – Lower  agea –
Sex Male Male – Male
Educational level achieved – Lowera Highera Lowera
Barthel index 0–80 (vs. > 80) – – – –
Follow-up in a region different from home region (vs. same 
region)
Different region – Different region Different region
Number of specialists visited in the past year Lowera Lowera Lowera Lowera
Being followed-up by the same vs. a different physician Same physician Same physician Same physician Same physician
Follow-up by a nurse (vs. no nurse follow-up) Follow-up by nurse Follow-up by nurse – Follow-up by nurse
Receiving support from others for healthcare (vs. only 
self-care)
– – – –
Number of different medicines taken Lowera Lowera Lowera Lowera
Treatment with SC/IV drugs (vs. no SC/IV treatment) – – – –
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allocation of healthcare responsibilities to individual health-
care providers; rather, it directs such responsibilities toward 
healthcare teams or healthcare systems [2].
5  Conclusions
This cross-sectional survey utilized the IEXPAC scale and 
involved a large sample of patients with chronic conditions 
(DM, HIV infection, IBD or rheumatic disease). The study 
clearly demonstrated that marked potential exists for health-
care quality improvements regarding helping patients to get 
information from the internet, to access medical records via 
mobile phone and internet and to communicate with other 
patients. The importance of follow-up by the same physi-
cian, as well as nurse follow-up, for enhancing healthcare 
quality were also emphasized, as was the significance of 
patients receiving help from others rather than adopting self-
care. Overall, use of the IEXPAC instrument has not yet 
been adopted universally in routine practice. However, IEX-
PAC assessment of the experiences of chronically ill patients 
may clearly redirect healthcare toward more patient-centered 
healthcare goals while facilitating integrated improvements 
in social care and long-term healthcare quality.
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